Reneuron Share Discussion Threads

[deltar] 31/10/2013 17:39

Put a x10 behind that when the successful trial results come through.

According to the World Health Organization, 15 million people suffer stroke worldwide each year. Of these, 5 million die and another 5 million are permanently disabled.

Each year in England, approximately 110,000
people have a first or recurrent stroke and a further 20,000 people have a
transient ischaemic attack. More than 900,000 people in England are
living with the effects of stroke, and half of these are dependent on other
people for help with everyday activities.
In England, stroke is estimated to cost the economy around £7 billion per
year. This comprises direct costs to the NHS of £2.8 billion (around
£5.5 million per 100,000 population), costs of informal care of £2.4 billion and
costs because of lost productivity and disability of £1.8 billion.
Stroke patients occupy around 20% of all acute hospital beds and 25% of long-term beds.

[stewart_25] 31/10/2013 09:02

Delta - they not having mine for less than 20p!!

[deltar] 30/10/2013 18:29

Analyst Research and Presentations
The following investment analysts currently provide research on ReNeuron:
Analyst Broker Recommendation Price Target
Navid Malik Cenkos Securities Buy 10p (short term target price)
23p (DCF valuation price)


Robin Campbell Merchant Securities Buy 33p

[stewart_25] 28/10/2013 15:32

Bouncing around here - next step up on next news. Does anyone know when an update is likely?

[deltar] 22/10/2013 08:08

Hopefully buildng a solid launch pad

[curlly] 21/10/2013 10:48

Are we coming to life??

[deltar] 06/10/2013 22:27

Dragon....agree its looking good nod nod.

[14dragon] 06/10/2013 20:49

Yep. But I expect the burning to give me hot cash in time. We shall see.

[rocket fuel] 06/10/2013 09:45

dragon, i'd say they have burnt 3 million in the last 6 months just doing the paperwork, then you can treble it when they get back to actual trials in the clinic.

[14dragon] 05/10/2013 17:30

Treble! That's fantastic news.
Thanks rocket.

[rocket fuel] 03/10/2013 23:34

oh well H1 over and done with three days ago, will be interesting to see the interims in december. as a matter of fact there have been no patients in clinic for the whole six months so will be very enlightening to see cash burn for the period. you can expect to treble it when they do eventually get back to work.

[heyho2] 02/10/2013 20:56

Welsh Government to be investigated over ReNeuron funding!

At least we now know why the share price has drifted back down to these levels again:

[heyho2] 26/9/2013 18:44

Reneuron's CSO (John Sinden) presenting tonight:

[14dragon] 23/9/2013 01:12

Has rocket shot himself in the foot?

[deltar] 22/9/2013 22:59

short away - gives us the opportunity to top up further before the big players arrive.

[peawacks] 22/9/2013 22:16

Gunpowder,treason and plot ?

[andrewcoughlin] 22/9/2013 20:45

I give it till November 5th. What do you say rocket?

[arooster] 22/9/2013 11:49

rocket fuel really good post, just a bit too optimistic for me, i think it will all be over by Christmas, so i have shorted all my worldly assets.

[andrewcoughlin] 21/9/2013 19:06

Your right heyho2, but what an amazing imagination rocket has!

[heyho2] 21/9/2013 18:28

RocketGive it a rest you're beginning to sound like a broken record.I don't mind a bit of lively debate but unsubstantiated bashing is out-of-order!

[rocket fuel] 21/9/2013 15:58

gotta laugh, it dont take them long to respond to a couple of informal objections does it?

i posted a cpl weeks back about nothing doing in the clinic yet and probably not till december if you're lucky and i also brought up the issue of no rns news yet re validation of a new CTX supplier.

one week later they release the rns update re news of new CTX supplier and a mention that trials will be open for patient recruitment by the end of the year. (that tells me actual trials will not commence till at least jan/feb next yr as it takes a while to recruit and give patients the ok for clinic)

rene cannot sustain its current market cap going forward in my opinion. it's all about hard cash burn going out with no revenue stream to be seen coming in here for many years ahead. FDA approval stage itself is likely to be 5yrs plus down the line i would imagine. where will the next multi million pound fundraising come from to get them that far? i doubt it will be milked from AIM again nor a jv.

my imaginary scenario here is that i can see the share price being bashed down to well below sub 1p over the next 18/24 months until its on it's knees with on-going potential future funding issues.
drive it down to around 0.2p and thats when a shiny new private company with a few familiar names on board turn up like a 'white knight' and offer 1p a share!
it will be deemed a good offer at the time and a nice 5 bagger to-boot for any traders who time it right.

it wouldn't be the first time i've seen that in the AIM bio-sector and indeed across all sectors of the AIM microcaps. all legal and above board!